Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 46 of 46 entries
View as:

A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04696393 Org: User:
Start: 01/06/21 End: 03/19/21 Due: 03/19/22

A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04565678 Org: User:
Start: 09/21/20 End: 12/03/20 Due: 12/03/21

Food Effect Study of AG-221 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02218346 Org: User:
Start: 08/31/14 End: 03/31/15 Due: 03/31/16

Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03245424 Org: User:
Start: - End: - Due: -

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT04536792 Org: User:
Start: 07/10/20 End: 12/19/23 Due: 12/19/24

A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT02476916 Org: User:
Start: 06/26/15 End: 04/02/25 Due: 04/02/26

Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03361358 Org: User:
Start: 03/01/18 End: 09/30/19 Due: 09/30/20

A Phase I Study of AG-348 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02108106 Org: User:
Start: 03/31/14 End: 08/31/14 Due: 08/31/15

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02492737 Org: User:
Start: 08/07/15 End: 03/21/18 Due: 03/21/19

Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin

Phase: N/A Priority: Normal
NCT ID: NCT03250598 Org: User:
Start: 08/09/17 End: 10/09/17 Due: 10/09/18

Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007

Phase: N/A Priority: Normal
NCT ID: NCT03853798 Org: User:
Start: 03/21/19 End: 07/03/24 Due: 07/03/25

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04472832 Org: User:
Start: 06/17/20 End: 11/23/20 Due: 11/23/21

Drug-Drug Interaction Study of AG120 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02831972 Org: User:
Start: 06/30/16 End: 10/31/16 Due: 10/31/17

A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881

Phase: N/A Priority: Normal
NCT ID: NCT04128787 Org: User:
Start: 09/30/19 End: 12/18/19 Due: 12/18/20

Food Effect Study of AG120 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02579707 Org: User:
Start: 10/31/15 End: 06/30/16 Due: 06/30/17

Study to Evaluate the Relative Bioavailability and Safety of the AG-348 Tablet and Capsule Formulations in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03397329 Org: User:
Start: 10/03/17 End: 11/13/17 Due: 11/13/18

A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04015687 Org: User:
Start: 07/15/19 End: 10/09/19 Due: 10/09/20

A Study to Evaluate AG-881 in Healthy Japanese and Non-Asian Participants

Phase: N/A Priority: Normal
NCT ID: NCT04145128 Org: User:
Start: 10/02/19 End: 12/18/19 Due: 12/18/20

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120

Phase: N/A Priority: Normal
NCT ID: NCT02489513 Org: User:
Start: 06/30/15 End: 10/31/15 Due: 10/31/16

Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06648824 Org: User:
Start: 10/17/24 End: 12/03/24 Due: 12/03/25

Japanese Bridging Study of Ivosidenib (AG-120) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03071770 Org: User:
Start: 03/31/17 End: 09/06/17 Due: 09/06/18